Target intelligence / Profile preview

Deleted in malignant brain tumors 1 like 1 (DMBT1L1)

Target
DMBT1L1
Molecular classification
Other (annotated as pseudogene; not classified as a receptor, enzyme, transporter, or canonical protein family)
01

Overview

Deleted in malignant brain tumors 1 like 1 (DMBT1L1) is an annotated human pseudogene, reported under several aliases including DMBT1P1 and ZP domain-containing protein LOC729800-like[1]. Unlike its paralog DMBT1, which encodes a multifunctional glycoprotein and putative tumor suppressor involved in pattern recognition and immune defense[5][7], DMBT1L1 lacks evidence for a functional protein product and is not regarded as a therapeutic target. DMBT1L1 appears as a genomic sequence resembling DMBT1 but with gene structure or sequence features classifying it as a pseudogene. No known drugs, biomarkers, or disease associations are reported for DMBT1L1 in genomic or pharmacological databases[1]. Relevant protein families such as “ZP domain-containing proteins” are referenced in the context of DMBT1’s structure (ZP domain, involved in extracellular matrix assembly and polymerization)[7][2], but there is no direct evidence that DMBT1L1 encodes a biologically active ZP domain protein. If further clarification is needed on DMBT1 (without “like 1”), note that DMBT1 is a protein-coding gene with important disease associations and biological functions, while DMBT1L1/DMBT1P1 is not[5][7][1].

Other names
DMBT1P1ZP domain-containing protein LOC729800-likedeleted in malignant brain tumors 1 pseudogene 1putative ZP domain-containing protein LOC729800DMBT1L1

Beyond the preview

Go deeper on Deleted in malignant brain tumors 1 like 1 (DMBT1L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deleted in malignant brain tumors 1 like 1 (DMBT1L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call